Trials / Completed
CompletedNCT01484106
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Cheetah Medical Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to test whether a fluid resuscitation protocol guided by non-invasive hemodynamic measures reduces the progression of organ dysfunction (defined by an increase in the Serial Organ Failure Assessment Score ≥ 1 over the first 72 hours) in sepsis patients presenting to the Emergency Department without evidence of shock.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fluid Resuscitation | In the Treatment group, this information will be used in a specific 4-hour treatment algorithm to guide fluid administration that is summarized in Figure 1. The information provided by the NICOM in response to the fluid bolus will be used to assess whether the subject is "fluid responsive" (FR). |
| OTHER | Standard of Care | Standard of Care |
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2011-12-02
- Last updated
- 2021-07-21
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01484106. Inclusion in this directory is not an endorsement.